Pfizer stock rises today as 2026 drug price hikes grab headlines again — what PFE investors are watching
NEW YORK, January 2, 2026, 13:56 ET — Regular session Pfizer Inc shares rose 0.8% to $25.09 on Friday, as investors digested renewed attention on U.S. drug pricing and early-year list-price changes. The timing matters. January is when drugmakers typically reset U.S. prices, and the moves can quickly become a political and regulatory flashpoint — especially as the Trump administration…